NAB001

DRUG2 trials

Sponsors

Promius Pharma, LLC

Conditions

Onychomycosis

Phase 3

Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

TerminatedNCT01208168

Promius Pharma, LLCOnychomycosis

Start: 2010-09-30End: 2012-07-31Updated: 2013-07-11

Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

TerminatedNCT01208129

Promius Pharma, LLCOnychomycosis

Start: 2010-09-30End: 2012-07-31Updated: 2013-07-11